查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1874589

全球细胞分离技术市场

Cell Separation Technologies
出版日期: | 出版商: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

全球细胞分离技术市场预计2030年将达到598亿美元

全球细胞分离技术市场规模在2024年估计为257亿美元，预计到2030年将达到598亿美元，在分析期（2024-2030年）内复合年增长率（CAGR）为15.1%。本报告分析的细分市场之一「实验室和研究机构」预计将以14.9%的复合年增长率成长，并在分析期结束时达到249亿美元。同时，「生物技术和製药」细分市场预计在分析期间将以16.4%的复合年增长率成长。

美国市场规模估计为71亿美元，而中国市场预计将以14.1%的复合年增长率成长。

预计2024年，美国细胞分离技术市场规模将达71亿美元。作为世界第二大经济体，中国预计到2030年市场规模将达到90亿美元，2024年至2030年的复合年增长率（CAGR）为14.1%。其他值得关注的区域市场分析包括日本和加拿大，预计在分析期内，这两个国家的复合年增长率将分别达到13.2%和12.6%。在欧洲，德国的复合年增长率预计将达到约11.0%。

全球细胞分离技术市场—主要市场趋势与驱动因素概述

细胞分离技术如何推动生物医学研究？

细胞分离技术正逐渐成为生物医学研究的基石。它们使科学家能够从异质混合物中分离出特定类型的细胞，从而为研究疾病机制、开发治疗方法和进行基础生物学研究提供关键支持。这些技术在免疫学、癌症研究和干细胞生物学等应用领域至关重要，因为在这些领域中，分离特定细胞群对于理解细胞行为和功能至关重要。例如，精确分离免疫细胞使研究人员能够研究身体对感染疾病和治疗方法的免疫反应，从而开发新型免疫疗法。在癌症研究中，将癌细胞与正常细胞分离可以对癌症进展和治疗反应进行详细分析。包括磁激活细胞分选（MACS）、萤光激活细胞分选（FACS）和微流体系统在内的各种技术被广泛用于实现这些目标，每种技术都根据细胞类型和所需的精度提供独特的优势。这些技术在研究和临床环境中的广泛应用，正使其在学术界和工业界的实验室中日益重要。

为什么细胞分离技术在治疗药物研发中如此重要？

细胞分离技术在治疗方法研发中发挥着至关重要的作用，尤其是在细胞治疗方法和个人化医疗领域。在再生医学和免疫疗法等领域，分离特定细胞类型对于生成可用于治疗的高纯度细胞群至关重要。例如，在CAR-T细胞疗法中，免疫细胞被分离、基因改造和扩增，然后重新註射到患者体内标靶化并摧毁癌细胞。分离细胞的纯度和活性是治疗成功的关键。同样，干细胞疗法利用相关技术从骨髓或组织分离干细胞，用于再生受损组织和治疗退化性疾病。除了用于治疗方法研发外，这些技术也应用于临床诊断。从血液或组织样本中分离特定细胞能够更准确地检测和后续观察疾病。实现高通量和高精度细胞分离的能力为个人化治疗方法的开发和精准医疗的发展开闢了新的可能性，在精准医疗中，治疗方法将根据每位患者独特的细胞特征量身定制。

技术创新如何改善细胞分离技术？

技术进步显着提高了细胞分离技术的效率、准确性和扩充性，使其在研发和临床应用中更容易取得且更可靠。其中一项关键创新是开发了自动化、高通量细胞分选系统，该系统能够以最少的人工干预快速处理大量样本。这些系统在药物研发和临床应用中尤其重要，因为速度和精确度至关重要。微流体技术彻底革新了细胞分离，使细胞能够在微米尺度上操控，实现更精确、更温和的分选技术。这减少了细胞损伤，提高了分离细胞的存活率。此外，诸如声学和介电泳分离等无标定技术的进步，为传统的标记方法提供了替代方案，并能保持细胞完整性，使其适用于精细应用。此外，将人工智慧 (AI) 和机器学习整合到细胞分选工作流程中，提高了我们分析和优化分选参数的能力，进一步提升了细胞分离的效率和准确性。这些创新正在推动下一代细胞分离技术的发展，并扩展其在单细胞分析、癌症研究和再生医学等领域的应用。

细胞分离技术市场的主要成长要素是什么？

细胞分离技术市场的成长受多种因素驱动，包括细胞研究的进步、个人化医疗的兴起以及治疗研发中对高纯度细胞群日益增长的需求。其中一个关键驱动因素是，在CAR-T细胞疗法和干细胞疗法等细胞疗法的研发过程中，对高效细胞分离的需求不断增长。这些疗法需要精确分离特定细胞类型以确保疗效和安全性，这推动了对先进分离技术的需求。自动化和高通量分选系统等技术创新使研究人员能够快速且准确地处理大量样本，进一步促进了市场成长。此外，基因组学和蛋白​​质组学领域单细胞分析的扩展，为需要高纯度细胞群进行深入分子研究的研究人员创造了新的细胞分离技术机会。免疫疗法和再生医学的兴起也推动了市场需求，因为这些疗法在治疗研发中高度依赖分离细胞。此外，政府和私人部门对生命科学研究的投入不断增加，加上癌症和自体免疫疾病等慢性病的日益普遍，都加速了先进细胞分离技术的需求。这些因素，以及细胞分离技术在临床诊断和药物研发领域应用的持续拓展，预计将在未来几年内推动细胞分离技术市场保持强劲成长。

部分：

依最终用户划分（研究机构、生技/製药业、其他最终用户）

受访公司范例

  • BD Biosciences
  • MilliporeSigma
  • Miltenyi Biotec GmbH
  • pluriSelect Life Science
  • StemCell Technologies Inc.
  • Terumo BCT, Inc.
  • Thermo Fisher Scientific, Inc.

人工智慧集成

我们正在利用检验的专家内容和人工智慧工具，改变您分析市场和竞争情报的方式。

Global Industry Analysts 没有依赖查询通用 LLM（大型语言模型）或产业专用的SLM（小型语言模型），而是建立了一个由世界各地领域专家精心整理的内容库，其中包括视频转录、博客、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

我们最新发布的报告纳入了关税对区域市场的影响，正如全球产业分析师预测的那样，关税将改变企业的竞争地位，而企业的竞争地位将取决于其总部所在地、製造地以及进出口（成品和OEM产品）。这种复杂多变的市场现实将透过微观和宏观市场动态影响竞争对手，包括销货成本增加、盈利下降以及供应链重组。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章 市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲
  • 亚太地区
  • 世界其他地区

第四章 竞赛

简介目录
Product Code: MCP10949

Global Cell Separation Technologies Market to Reach US$59.8 Billion by 2030

The global market for Cell Separation Technologies estimated at US$25.7 Billion in the year 2024, is expected to reach US$59.8 Billion by 2030, growing at a CAGR of 15.1% over the analysis period 2024-2030. Research Laboratories & Institutes End-Use, one of the segments analyzed in the report, is expected to record a 14.9% CAGR and reach US$24.9 Billion by the end of the analysis period. Growth in the Biotechnology & Pharmaceutical Industries End-Use segment is estimated at 16.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$7.1 Billion While China is Forecast to Grow at 14.1% CAGR

The Cell Separation Technologies market in the U.S. is estimated at US$7.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$9.0 Billion by the year 2030 trailing a CAGR of 14.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 13.2% and 12.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 11.0% CAGR.

Global Cell Separation Technologies Market - Key Trends and Drivers Summarized

How Are Cell Separation Technologies Advancing Biomedical Research?

Cell separation technologies have become fundamental to biomedical research, providing scientists with the ability to isolate specific cell types from heterogeneous mixtures, which is critical for studying disease mechanisms, developing therapies, and conducting basic biological research. These technologies are essential for applications such as immunology, cancer research, and stem cell biology, where isolating specific cell populations is crucial to understanding cellular behavior and function. By enabling the precise separation of immune cells, for instance, researchers can investigate immune responses to infections or therapies, leading to the development of new immunotherapies. In cancer research, separating tumor cells from healthy cells allows for detailed analysis of how cancer progresses and responds to treatments. Various techniques, such as magnetic-activated cell sorting (MACS), fluorescence-activated cell sorting (FACS), and microfluidic-based systems, are commonly used to achieve these goals, each offering unique advantages depending on the cell type and the level of precision required. The widespread use of these technologies across research and clinical settings has expanded their relevance in both academic and industrial laboratories.

Why Are Cell Separation Technologies Critical for Therapeutic Development?

Cell separation technologies play a pivotal role in therapeutic development, particularly in the creation of cell-based therapies and personalized medicine. In fields such as regenerative medicine and immunotherapy, isolating specific cell types is essential for generating high-purity cell populations that can be used for therapeutic purposes. For example, in CAR-T cell therapy, immune cells are isolated, genetically engineered, expanded, and reintroduced to a patient to target and destroy cancer cells. The purity and viability of the isolated cells are critical for the success of these therapies. Similarly, in stem cell therapies, cell separation technologies are used to isolate stem cells from bone marrow or other tissues, allowing for their use in regenerating damaged tissues or treating degenerative diseases. In addition to therapeutic development, these technologies are used in clinical diagnostics, where separating specific cells from blood or tissue samples enables more accurate disease detection and monitoring. The ability to achieve high-throughput and high-precision cell isolation has opened new possibilities in developing targeted treatments and advancing precision medicine, where therapies are tailored to individual patients based on their unique cellular profiles.

How Are Technological Innovations Enhancing Cell Separation Techniques?

Technological advancements have significantly enhanced the efficiency, accuracy, and scalability of cell separation technologies, making them more accessible and reliable for both research and clinical applications. One of the key innovations is the development of automated, high-throughput cell sorting systems, which enable the rapid processing of large sample volumes with minimal human intervention. These systems are particularly valuable in drug discovery and clinical settings, where speed and precision are critical. Microfluidic technologies, which allow for the manipulation of cells at the microscale, have revolutionized cell separation by enabling more precise and gentle sorting methods, reducing cell damage and improving the viability of isolated cells. Additionally, advancements in label-free techniques, such as acoustic and dielectrophoresis-based separation, provide alternatives to traditional labeling methods, preserving cell integrity and making these technologies suitable for sensitive applications. Moreover, the integration of artificial intelligence (AI) and machine learning into cell sorting workflows has improved the ability to analyze and optimize sorting parameters, further increasing the efficiency and accuracy of cell separation. These innovations are driving the next generation of cell separation technologies, expanding their applications in areas like single-cell analysis, cancer research, and regenerative medicine.

What Are the Key Growth Drivers in the Cell Separation Technologies Market?

The growth in the cell separation technologies market is driven by several factors, including advancements in cell-based research, the rise of personalized medicine, and the increasing demand for high-purity cell populations in therapeutic development. One of the primary drivers is the growing need for efficient cell separation in the development of cell-based therapies, such as CAR-T cell therapy and stem cell treatments. These therapies require the precise isolation of specific cell types to ensure their effectiveness and safety, fueling demand for advanced separation technologies. Technological innovations, such as automated and high-throughput sorting systems, are making it easier for researchers to process large numbers of samples quickly and accurately, further contributing to market growth. Additionally, the expansion of single-cell analysis in genomics and proteomics is creating new opportunities for cell separation technologies, as researchers require highly purified cell populations for detailed molecular studies. The rise of immunotherapy and regenerative medicine, both of which rely heavily on isolated cells for treatment development, is also driving demand. Furthermore, increasing government and private investment in life sciences research, coupled with the growing prevalence of chronic diseases like cancer and autoimmune disorders, is accelerating the need for advanced cell separation techniques. These factors, along with the expanding use of cell separation in clinical diagnostics and drug discovery, are expected to sustain the robust growth of the cell separation technologies market in the years to come.

SCOPE OF STUDY:

The report analyzes the Cell Separation Technologies market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

End-Use (Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 43 Featured) -

  • BD Biosciences
  • MilliporeSigma
  • Miltenyi Biotec GmbH
  • pluriSelect Life Science
  • StemCell Technologies Inc.
  • Terumo BCT, Inc.
  • Thermo Fisher Scientific, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • Global Economic Update
    • Cell Separation Technologies - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Chronic Diseases Expands Use of Cell Separation in Diagnostics and Research
    • Rising Demand for Immunotherapy Expands Market for Cell Separation Technologies
    • Advancements in Microfluidics Propel Growth in Precision Cell Separation
    • Increasing Focus on Single-Cell Analysis Drives Adoption of Advanced Separation Technologies
    • Growing Application of Cell Separation in Cancer Research Strengthens Market Growth
    • Expansion of Stem Cell Therapy Boosts Demand for Efficient Cell Separation Solutions
    • Increased Need for High-Purity Cells in Biopharmaceutical Production Fuels Market Expansion
    • Rising Use of Cell Separation Technologies in Personalized Medicine Propels Market Growth
    • Adoption of Magnetic and Fluorescence-Activated Cell Sorting (MACS and FACS) Strengthens Cell Separation Market
    • Advances in Acoustic and Dielectrophoresis-Based Separation Drive Innovation in the Market
    • Increased Focus on Regenerative Medicine Fuels Demand for Sophisticated Cell Separation Techniques
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Cell Separation Technologies Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Cell Separation Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Cell Separation Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Cell Separation Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Research Laboratories & Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Research Laboratories & Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Research Laboratories & Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Biotechnology & Pharmaceutical Industries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Biotechnology & Pharmaceutical Industries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Biotechnology & Pharmaceutical Industries by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cell Separation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 15: USA Historic Review for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: USA 15-Year Perspective for Cell Separation Technologies by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 17: Canada Recent Past, Current & Future Analysis for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 18: Canada Historic Review for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: Canada 15-Year Perspective for Cell Separation Technologies by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Cell Separation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: Japan Historic Review for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: Japan 15-Year Perspective for Cell Separation Technologies by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Cell Separation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 23: China Recent Past, Current & Future Analysis for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: China Historic Review for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: China 15-Year Perspective for Cell Separation Technologies by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Cell Separation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Cell Separation Technologies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Cell Separation Technologies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: Europe 15-Year Perspective for Cell Separation Technologies by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: Europe 15-Year Perspective for Cell Separation Technologies by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Cell Separation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 32: France Recent Past, Current & Future Analysis for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: France Historic Review for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: France 15-Year Perspective for Cell Separation Technologies by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Cell Separation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 35: Germany Recent Past, Current & Future Analysis for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Germany Historic Review for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Germany 15-Year Perspective for Cell Separation Technologies by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 38: Italy Recent Past, Current & Future Analysis for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Italy Historic Review for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Italy 15-Year Perspective for Cell Separation Technologies by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Cell Separation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 41: UK Recent Past, Current & Future Analysis for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: UK Historic Review for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: UK 15-Year Perspective for Cell Separation Technologies by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 44: Rest of Europe Recent Past, Current & Future Analysis for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Rest of Europe Historic Review for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Rest of Europe 15-Year Perspective for Cell Separation Technologies by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Cell Separation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 47: Asia-Pacific Recent Past, Current & Future Analysis for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Asia-Pacific Historic Review for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Asia-Pacific 15-Year Perspective for Cell Separation Technologies by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 50: Rest of World Recent Past, Current & Future Analysis for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Rest of World Historic Review for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Rest of World 15-Year Perspective for Cell Separation Technologies by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION